2006年更新版加拿大骨质疏松症共识会议
Canadian Consensus Conference on osteoporosis, 2006 update.
作者信息
Brown Jacques P, Fortier Michel, Frame Heather, Lalonde André, Papaioannou Alexandra, Senikas Vyta, Yuen Chui Kin
机构信息
Quebec QC.
出版信息
J Obstet Gynaecol Can. 2006 Feb;28(2 Suppl 1):S95-112. doi: 10.1016/s1701-2163(16)32087-4.
OBJECTIVE
To provide guidelines for the health care provider on the diagnosis and clinical management of postmenopausal osteoporosis.
OUTCOMES
Strategies for identifying and evaluating high-risk individuals, the use of bone mineral density (BMD) and bone turnover markers in assessing diagnosis and response to management, and recommendations regarding nutrition, physical activity, and the selection of pharmacologic therapy to prevent and manage osteoporosis.
EVIDENCE
MEDLINE and the Cochrane database were searched for articles in English on subjects related to osteoporosis diagnosis, prevention, and management from March 2001 to April 2005. The authors critically reviewed the evidence and developed the recommendations according to the Journal of Obstetrics and Gynaecology Canada's methodology and consensus development process.
VALUES
The quality of evidence is rated using the criteria described in the report of the Canadian Task Force on the Periodic Health Examination. Recommendations for practice are ranked according to the method described in this report.
SPONSORS
The development of this consensus guideline was supported by unrestricted educational grants from Berlex Canada Inc., Lilly Canada, Merck Frosst, Novartis, Novogen, Novo Nordisk, Proctor and Gamble, Schering Canada, and Wyeth Canada.
目的
为医疗保健人员提供绝经后骨质疏松症诊断及临床管理的指南。
结果
识别和评估高危个体的策略、骨密度（BMD）和骨转换标志物在评估诊断及管理反应中的应用，以及关于营养、体育活动和预防及管理骨质疏松症药物治疗选择的建议。
证据
检索了MEDLINE和Cochrane数据库，查找2001年3月至2005年4月期间与骨质疏松症诊断、预防和管理相关的英文文章。作者严格审查了证据，并根据《加拿大妇产科杂志》的方法和共识制定过程制定了建议。
价值
使用加拿大定期健康检查特别工作组报告中描述的标准对证据质量进行评级。实践建议根据本报告中描述的方法进行排序。
资助者
本共识指南的制定得到了加拿大贝林公司、礼来加拿大公司、默克弗罗斯特公司、诺华公司、诺沃金公司、诺和诺德公司、宝洁公司、先灵葆雅加拿大公司和惠氏加拿大公司提供的无限制教育资助。
Zotero 插件